Quality of Life

New Expert video series on Quality of Life in melanoma patients with Professor Roger Olofsson Bagge

The World Health Organization (WHO) defines Quality of Life (QoL) as an individual’s perception of their position in life in the context of the culture and value systems in which they live, and in relation to their goals, expectations, standards, and concerns. But how does this translate to cancer patients? When, where and how should a patient’s QoL be evaluated? And maybe more importantly, in what ways can QoL be used to guide each patient’s treatment?

We sat down with Professor Roger Olofsson Bagge from Sahlgrenska University Hospital to hear his insights to these important questions. Professor Olofsson Bagge has published several papers on the topic and is working on the development of a new QoL evaluation tool for stage III melanoma.

You can now watch this 3-part expert opinion video series to learn more about Professor Olofsson Bagge’s insights on QoL in melanoma patients. Each part focuses on a specific question; from what is the status of QoL in melanoma patients to how QoL measures can be used in clinical practice.